Setting the Stage: Are you following the right GMPs
Date: Tuesday, June 9, 2026
Time: 1:00 pm – 1:30 pm EDT
Fee: Free for members
This session will set the stage for the subsequent GMP training series for low-risk drugs and natural health products and is especially important if you do not understand what a low-risk drug is in Canada.
This session will remind everyone where this definitional consideration exists across Part C of the F&DR (e.g. Division 2, Division 1 and Division 01A), the Canada-US-Mexico Free Trade Agreement (CUSMA) and several Health Canada Guidance Documents/Policies.
Preparing Audit Corrective Action & Preventive Action (CAPA) Responses
Date: Tuesday, June 23, 2026
Time: 1:00 pm – 2:00 pm EDT
Fee: $295 Members / $395 Non Members
This session will prepare you for the Health Product Compliance Directorate’s Red Tape Reduction initiative for a Modernized Suspension Framework. This initiative will modernize the Natural Health Product Regulations with a goal to implement a more agile suspension framework that is separated from the CAPA process.
This course will prepare those in the Natural Health Product space to understand the importance of CAPA’s in relation to audit responses and what to expect under this RTR initiative.
This session will also be valuable for those in the drug realm in preparing the same.
Customer Complaints
Date: Tuesday, July 7, 2026
Time: 1:00 pm – 2:00 pm EDT
Fee: $295 Members / $395 Non Members
Customer complaint systems are linked to several regulatory requirements. This session will:
Help you understand the big picture across legislation and the importance of a customer complaint system.
Highlight a key point in guidance where you may not need to investigate complaints.
Demonstrate some commonly used processes for establishing a customer complaint system.
Detail what you need to have on hand should Health Canada receive a complaint, and they reach out to you.
Process Validation (aka Process Consistency)
Date: Tuesday, July 21, 2026
Time: 1:00 pm – 2:00 pm EDT
Fee: $295 Members / $395 Non Members
This session will detail the requirements for “Process Consistency” for low-risk drugs versus “Process Validation” for higher risk drugs.
This session will help you:
Understand what process consistency means.
Understand any international implications.
Learn some statistical tools you can use to demonstrate process consistency.
Stability
Date: Tuesday, August 18, 2026
Time: 1:00 pm – 2:30 pm EDT
Fee: $295 Members / $395 Non Members
Stability requirements for low-risk drug products are substantially different for low-risk drug and natural health products. This course will help you:
Understand the key differences between stability testing for low-risk drugs and higher risk drugs and natural health products.
Leverage your understanding of stability requirements to allow you to demonstrate to auditors which guidelines apply and which ones do not.
A short quiz will be administered at the end of each session. Participation in the quiz—and eligibility to receive a training certificate upon successful completion—is limited to individuals who have registered electronically through the LogMeIn© GoTo Training program.
Presenter
Richard Parcels
Richard Parcels is the Assistant Director, Regulation & Market Access for Cosmetics Alliance Canada. He works to enhance and protect the ability of member companies to conduct business effectively in Canada by fostering industry and government cooperation and by using sound science and risk-based approaches to inform and shape regulation, policy and guidance.
Richard has over twenty years of experience in the pharmaceutical, natural health product, cosmetic and medical device fields. He obtained a B.Sc. in Microbiology from the University of Guelph and has previously worked at Agriculture Canada, Warner-Lambert Parke-Davis, AstraZeneca, Estee Lauder and as an industry consultant for 12 years. He specializes in regulatory affairs, quality systems, training and auditing.
